On December 11, 2020, the US Food and Drug Administration (FDA) granted an emergency use approval (EUA) for the Pfizer-BioNTech COVID-19 vaccine. A week afterwards, the FDA approved Moderna’s COVID-19 vaccine. Now, almost two years later, Moderna and Pfizer will begin clinical trials to monitor adverse health effects associated with the COVID-19 vaccinations, such as myocarditis (inflammation of the cardiac muscle).
Pfizer is just getting started with clinical testing to see if there are any health hazards related to their own vaccine. The experiment, which will be conducted in cooperation with the Pediatric Heart Network, will concentrate on vaccine recipients that have had heart problems after receiving the COVID-19 vaccine. Patients will be monitored for five years as part of the clinical trials.
Enrollment for the research in the United States and Canada has not yet begun. According to Dr. Dongngan Truong, who is a pediatrician at the College of Utah Medical and a co-lead on the Pfizer project, the research team already has discovered more than 250 individuals with myocarditis.
“The scientists will also compare the individuals to a group of patients with the multi-system inflammatory disorder in children, better known as MIS-C, which is linked with a COVID infection,” NBC News said on Friday.
The first discoveries are not anticipated to be made public until next year.
Moderna will perform their own research on the potential side effects of COVID vaccines in 5 nations, with the help of the European Medicines Agency. The results among those studies are not anticipated to be made public before next summer.
Dr. Paul Burton, Moderna’s medical director, confessed that scientists are unsure what causes the potential heart problems caused by the COVID-19 vaccination.
“We really do not understand it as of yet,” Burton confessed to NBC News. “There’s no good method for explaining it.”
Burton hypothesized that the spike protein in the vaccination would produce an adverse reaction inside the body, resulting in cardiac inflammation.